Figure 5.
Individual and mean changes from placebo to active treatment and from baseline to active treatment in (A) submaximal exercise heart rate, (B) submaximal exercise respiratory quotient (RQ), (C) peak exercise workload and (D) peak oxygen uptake in 19 patients with McArdle disease in a double‐blind crossover study investigating the effect of 14 days treatment with triheptanoin.